[Skip to Content]
[Skip to Content Landing]
December 1970

Mitral Valve Replacement With Autologous Tissue

Author Affiliations

From the departments of surgery, National Heart Hospital (Drs. Gonzales-Lavin, Geens, and Ross) and Guy's Hospital (Dr. Ross), London.

Arch Surg. 1970;101(6):760-764. doi:10.1001/archsurg.1970.01340300116019

Mitral valve replacement utilizing autologous fascia lata has been undertaken in 65 patients with an operative mortality of 13.8%. All the survivors are greatly improved; a marked increase in exercise tolerance and a decrease in heart size are evident in all but one. Seven percent of the patients developed an apical systolic murmur after surgery; however, moderate mitral regurgitation was found in only one patient. Autologous fascia lata is fashioned into a three-leaflet valve attached to a rigid frame. It is nonthrombogenic and offers excellent hemodynamics. This initial experience has encouraged the authors to continue with this method of valve replacement.